Emergent Biosolutions, Inc. News Headlines

EBS 
$26.98
*  
0.13
0.48%
Get EBS Alerts
*Delayed - data as of Dec. 18, 2014  -  Find a broker to begin trading EBS now
Exchange: NYSE
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
Viewing
Filtered By
Ordered By
Alnylam Jumps on Positive Patisiran Data from Phase II Study - Analyst Blog
10/14/2014 3:45:00 PM - Zacks.com


Protalix BioTherapeutics, Inc. (PLX) in Focus: Stock Surges 11.4% - Tale of the Tape
10/14/2014 8:18:11 AM - Zacks.com


Alnylam Pharmaceuticals (ALNY) Jumps: Stock Rises 19% - Tale of the Tape
10/14/2014 8:04:00 AM - Zacks.com


Prosensa Holding N.V. (RNA) in Focus: Stock up 8.5% - Tale of the Tape
10/14/2014 7:44:00 AM - Zacks.com


Vical Incorporated (VICL) in Focus: Stock Soars 12% - Tale of the Tape
10/14/2014 7:43:59 AM - Zacks.com


Exact Sciences (EXAS) Looks Strong: Stock Surges 35.8% - Tale of the Tape
10/13/2014 7:44:00 AM - Zacks.com


Weakness Seen in Momenta Pharmaceuticals (MNTA): Stock Tumbles 13.5% - Tale of the Tape
10/13/2014 7:30:00 AM - Zacks.com


XOMA Starts Phase I Study on XOMA 358 for Hyperinsulinism - Analyst Blog
10/10/2014 4:10:00 PM - Zacks.com


Emergent BioSolutions Revamps Business to Drive Earnings - Analyst Blog
10/8/2014 4:50:00 PM - Zacks.com


Emergent BioSolutions Initiates Pivotal Study on BioThrax - Analyst Blog
9/24/2014 4:20:00 PM - Zacks.com


Emergent Begins Study To Support Licensure Of BioThrax Production At New Plant
9/23/2014 7:32:00 AM - RTT News


Emergent BioSolutions, MorphoSys Tie Up on Cancer Candidate - Analyst Blog
8/20/2014 5:08:00 PM - Zacks.com


Emergent BioSolutions, Inc. (EBS): New Analyst Report from Zacks Equity Research - Zacks Equity Research Report
8/12/2014 7:00:00 AM - Zacks.com


Emergent BioSolutions Misses on Earnings, Ups Revenue View - Analyst Blog
8/11/2014 8:50:00 AM - Zacks.com


Will Emergent BioSolutions (EBS) Earnings Disappoint in Q2? - Analyst Blog
8/6/2014 4:45:00 PM - Zacks.com


Amazon Offers Low-End EC2 Instances (revised) - Analyst Blog
7/7/2014 12:15:58 PM - Zacks.com


Amazon Offers Low-end EC2 Instances - Analyst Blog
7/2/2014 5:05:00 PM - Zacks.com


Biodel Q2 Loss Wider Than Expected - Analyst Blog
5/16/2014 9:20:00 AM - Zacks.com


Healthcare Stocks Adding to Day-Long Surge; Emergent BioSolutions Slumps After Street.com Downgrade
5/12/2014 2:58:05 PM - MT Newswires


Sector Update: Healthcare
5/12/2014 2:55:22 PM - MT Newswires


Shares Continue to fall on Emergent BioSolutions' Wider Loss - Analyst Blog
5/12/2014 9:10:00 AM - Zacks.com


Healthcare Stocks Nudging Back into the Green; Emergent BioSciences Declines After Q1 Miss, Weak Q2 Outlook
5/9/2014 2:39:38 PM - MT Newswires


Sector Update: Healthcare
5/9/2014 2:38:57 PM - MT Newswires


J&J /Gilead HCV Combo Drug Filed - Analyst Blog
5/8/2014 3:55:00 PM - Zacks.com


Emergent's BioThrax Gets Orphan Drug Status - Analyst Blog
4/24/2014 6:10:01 PM - Zacks.com